Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Heslet

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Ugeskrift for Laeger|July 31, 2003
[Dishonesty in clinical trials is expensive for the society 1]Lars Heslet, Jorn Dalsgaard Nielsen, Jens Schierbeck
International Journal of General Medicine|February 10, 2012
Acute radiation syndrome (ARS) - treatment of the reduced host defenseLars Heslet, Christiane Bay, Steen Nepper-Christensen
Ugeskrift for Laeger|February 23, 2007
[Methods for cost-effectiveness evaluation of intensive care]Lars Heslet, Jakob Steen Andersen, Hans Keiding
Biologics : Targets & Therapy|March 16, 2012
Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigmLars Heslet, Jørn Dalsgaard Nielsen, Steen Nepper-Christensen
Ugeskrift for Laeger|February 23, 2007
[Intensive care--beneficial?]Else Tønnesen, Palle Toft, Jan Bonde, et al.
Ugeskrift for Laeger|March 31, 2004
[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis]Lars Heslet, Jørn Dalsgaard Nielsen, Jens Schierbeck, et al.
Microsurgery|July 27, 2004
Salvage of free flaps after venous thrombosis: case reportChristian T Bonde, Lars Heslet, Erik Jansen, et al.
Ugeskrift for Laeger|July 1, 2005
[Severe progress of septic shock with Mycobacterium tuberculosis infection]Johan Joakim Cordtz, Nanna Reiter, Kjeld A Jensen, et al.
Ugeskrift for Laeger|February 22, 2005
[Antibiotic treatment in four departments of a university hospital. A descriptive period prevalence study]Henriette Ytting, Lene Terslev, Michael Tvede, et al.
Ugeskrift for Laeger|February 23, 2007
[Critical care research]Anders Perner, Lars Heslet, Anders Larsson, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Ugeskrift for Laeger|July 31, 2003
[Dishonesty in clinical trials is expensive for the society 1]Lars Heslet, Jorn Dalsgaard Nielsen, Jens Schierbeck
International Journal of General Medicine|February 10, 2012
Acute radiation syndrome (ARS) - treatment of the reduced host defenseLars Heslet, Christiane Bay, Steen Nepper-Christensen
Ugeskrift for Laeger|February 23, 2007
[Methods for cost-effectiveness evaluation of intensive care]Lars Heslet, Jakob Steen Andersen, Hans Keiding
Biologics : Targets & Therapy|March 16, 2012
Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigmLars Heslet, Jørn Dalsgaard Nielsen, Steen Nepper-Christensen
Ugeskrift for Laeger|February 23, 2007
[Intensive care--beneficial?]Else Tønnesen, Palle Toft, Jan Bonde, et al.
Ugeskrift for Laeger|March 31, 2004
[Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis]Lars Heslet, Jørn Dalsgaard Nielsen, Jens Schierbeck, et al.
Microsurgery|July 27, 2004
Salvage of free flaps after venous thrombosis: case reportChristian T Bonde, Lars Heslet, Erik Jansen, et al.
Ugeskrift for Laeger|July 1, 2005
[Severe progress of septic shock with Mycobacterium tuberculosis infection]Johan Joakim Cordtz, Nanna Reiter, Kjeld A Jensen, et al.
Ugeskrift for Laeger|February 22, 2005
[Antibiotic treatment in four departments of a university hospital. A descriptive period prevalence study]Henriette Ytting, Lene Terslev, Michael Tvede, et al.
Ugeskrift for Laeger|February 23, 2007
[Critical care research]Anders Perner, Lars Heslet, Anders Larsson, et al.
Pageof 3